Latest filing published 28 May 2019 for Adamis Pharmaceuticals Corp, €70k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Richard C. Williams span 2 companies, the busiest being Ista Pharmaceuticals Inc and Adamis Pharmaceuticals Corp. Over a trading history stretching from 20 October 2004 to 24 May 2019, the count stands at 16 filings.
Market trades split into 9 purchases (€154k) and 1 sale (€4.1M). The net balance comes to €4.0M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants. So far in 2019, the count stands at 1 purchase and no sales.
The median purchase comes to €6,099.
The newest entry dates from 28 May 2019: an open-market purchase of €70k, in Adamis Pharmaceuticals Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations